Seed: Vida agent + health domain -- 40 claims #15
8 changed files with 42 additions and 9 deletions
|
|
@ -0,0 +1,37 @@
|
||||||
|
---
|
||||||
|
description: Devoted Health grew Medicare Advantage membership 121 percent while UnitedHealth shed 1 million members and Humana faces a 3.5 billion dollar star rating headwind because purpose-built full-stack integration on the Orinoco platform generates genuine quality outcomes rather than depending on coding arbitrage that CMS is systematically eliminating
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
created: 2026-03-06
|
||||||
|
source: "Devoted Health membership data 2025-2026; CMS 2027 Advance Notice February 2026; UnitedHealth 2026 guidance; Humana star ratings impact analysis; TSB Series F and F-Prime due diligence"
|
||||||
|
confidence: likely
|
||||||
|
---
|
||||||
|
|
||||||
|
# Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening
|
||||||
|
|
||||||
|
Devoted Health's Medicare Advantage membership grew 121 percent, making it the fastest-growing MA plan in the country during a period when the largest incumbents are contracting. UnitedHealth expects to lose 1 million MA members in 2026 from repricing driven by margin pressure. Humana faces an estimated $3.5 billion headwind from star rating declines. The divergence is structural, not cyclical.
|
||||||
|
|
||||||
|
**Why Devoted grows while incumbents shrink.** The CMS regulatory environment is systematically eliminating the profit mechanisms that acquisition-based vertical integration depends on. Since [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]], retrospective chart review coding — the primary revenue lever for Optum/UHC and CenterWell/Humana — is being excluded from risk adjustment. Simultaneously, CMS is tightening star ratings methodology toward member experience and clinical outcomes, away from administrative process metrics.
|
||||||
|
|
||||||
|
Devoted was built from scratch on the Orinoco platform — a unified AI-native operating system that integrates insurance, care delivery, and member engagement on a single technology stack. Unlike acquisition-based integrators who stitch together legacy systems from purchased companies, Devoted's clinical data flows through Orinoco as part of actual care delivery. Chart review exclusion has minimal impact because Devoted's risk scores reflect genuine clinical encounters, not after-the-fact coding.
|
||||||
|
|
||||||
|
**The cost advantage.** Devoted operates with a structural cost advantage estimated at 9 points of medical loss ratio below incumbents whose economics depend on coding arbitrage and intercompany transfer pricing. This advantage widens as CMS tightens because Devoted's economics improve with genuine quality competition while incumbents' economics deteriorate as arbitrage mechanisms are closed.
|
||||||
|
|
||||||
|
**Star ratings as competitive moat.** Devoted achieved a 4.19 weighted star rating through genuine member experience — the "Treat Everyone Like Family" prime directive operationalized through technology. In an environment where CMS is shifting star methodology toward outcomes and experience, high organic star ratings become a compounding advantage: quality bonus payments fund further investment in care delivery, which improves outcomes, which sustains ratings.
|
||||||
|
|
||||||
|
**The proof of concept for purpose-built integration.** Since [[four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable]], Devoted's growth during CMS tightening is the strongest evidence that purpose-built full-stack integration outperforms acquisition-based integration when the regulatory environment penalizes coding arbitrage. The aligned partner model — building technology and care delivery together rather than acquiring existing systems — proves more durable when the environment shifts to genuine quality competition.
|
||||||
|
|
||||||
|
Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9 billion annual technology spend directed at optimizing existing infrastructure (consolidating 18 EMRs, AI scribing within legacy workflows) rather than rebuilding around prevention is textbook proxy inertia. The margin from coding arbitrage rationally prevents pursuit of the purpose-built alternative.
|
||||||
|
|
||||||
|
---
|
||||||
|
|
||||||
|
Relevant Notes:
|
||||||
|
- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] -- the regulatory catalyst that advantages purpose-built models
|
||||||
|
- [[four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable]] -- the structural landscape in which Devoted competes
|
||||||
|
- [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] -- why incumbents cannot pivot to the purpose-built model
|
||||||
|
- [[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]] -- Devoted's atoms-plus-bits integration at the care delivery level
|
||||||
|
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- Devoted demonstrates what genuine full-risk VBC looks like
|
||||||
|
- [[anti-payvidor legislation targets all insurer-provider integration without distinguishing acquisition-based arbitrage from purpose-built care delivery]] -- the regulatory risk that could affect Devoted despite its structural differentiation
|
||||||
|
|
||||||
|
Topics:
|
||||||
|
- [[health and wellness]]
|
||||||
|
|
@ -1,6 +1,6 @@
|
||||||
---
|
---
|
||||||
description: Preventive health platform co-started by Zachary Werner and Mark Hyman offering 100-plus lab tests and AI-powered MRI for 499 per year with 350M total raised at 2.5B valuation using Costco model of break-even testing with membership margin
|
description: Preventive health platform co-started by Zachary Werner and Mark Hyman offering 100-plus lab tests and AI-powered MRI for 499 per year with 350M total raised at 2.5B valuation using Costco model of break-even testing with membership margin
|
||||||
type: analysis
|
type: claim
|
||||||
domain: health
|
domain: health
|
||||||
created: 2026-02-21
|
created: 2026-02-21
|
||||||
source: "Zachary Werner profile research, Devoted Health Series G deck references, a16z Series A announcement June 2024, Redpoint Series B announcement November 2025"
|
source: "Zachary Werner profile research, Devoted Health Series G deck references, a16z Series A announcement June 2024, Redpoint Series B announcement November 2025"
|
||||||
|
|
|
||||||
|
|
@ -3,8 +3,6 @@ description: Kaisers 1955 legal separation into health plan hospitals and physic
|
||||||
type: claim
|
type: claim
|
||||||
domain: health
|
domain: health
|
||||||
created: 2026-02-20
|
created: 2026-02-20
|
||||||
company: "Devoted Health"
|
|
||||||
deal_stage: active
|
|
||||||
source: "HMO Act of 1973 legislative history; Kaiser Permanente corporate structure; DOJ Kaiser $556M FCA settlement 2026; Frier Levitt POP Act analysis 2025; AJMC Break Up Big Medicine analysis February 2026"
|
source: "HMO Act of 1973 legislative history; Kaiser Permanente corporate structure; DOJ Kaiser $556M FCA settlement 2026; Frier Levitt POP Act analysis 2025; AJMC Break Up Big Medicine analysis February 2026"
|
||||||
confidence: likely
|
confidence: likely
|
||||||
---
|
---
|
||||||
|
|
|
||||||
|
|
@ -1,6 +1,6 @@
|
||||||
---
|
---
|
||||||
description: Finnish smart ring maker dominates wearable ring category at $11B valuation with $500M revenue, defended by ITC patent action against Samsung, while deliberately shifting from male fitness demographic to women in their early twenties who show high-80s 12-month retention
|
description: Finnish smart ring maker dominates wearable ring category at $11B valuation with $500M revenue, defended by ITC patent action against Samsung, while deliberately shifting from male fitness demographic to women in their early twenties who show high-80s 12-month retention
|
||||||
type: analysis
|
type: claim
|
||||||
domain: health
|
domain: health
|
||||||
created: 2026-02-17
|
created: 2026-02-17
|
||||||
source: "Oura company announcements 2024-2026; CNBC October 2025; TechCrunch October 2025; Crunchbase funding data; ITC patent filing November 2025"
|
source: "Oura company announcements 2024-2026; CNBC October 2025; TechCrunch October 2025; Crunchbase funding data; ITC patent filing November 2025"
|
||||||
|
|
|
||||||
|
|
@ -1,6 +1,6 @@
|
||||||
---
|
---
|
||||||
description: Boston-based fitness wearable with $3.6B stale valuation from 2021 and no new priced round in 4 years faces competitive pressure from Oura's faster growth plus regulatory risk from FDA blood pressure confrontation while targeting a 2027 IPO
|
description: Boston-based fitness wearable with $3.6B stale valuation from 2021 and no new priced round in 4 years faces competitive pressure from Oura's faster growth plus regulatory risk from FDA blood pressure confrontation while targeting a 2027 IPO
|
||||||
type: analysis
|
type: claim
|
||||||
domain: health
|
domain: health
|
||||||
created: 2026-02-17
|
created: 2026-02-17
|
||||||
source: "WHOOP company announcements 2020-2026; Bloomberg November 2025; Forbes; FDA warning letter July 2025; Sacra research; Getlatka revenue data"
|
source: "WHOOP company announcements 2020-2026; Bloomberg November 2025; Forbes; FDA warning letter July 2025; Sacra research; Getlatka revenue data"
|
||||||
|
|
|
||||||
|
|
@ -3,8 +3,6 @@ description: Both the Patients Over Profits Act and Break Up Big Medicine Act wo
|
||||||
type: claim
|
type: claim
|
||||||
domain: health
|
domain: health
|
||||||
created: 2026-02-20
|
created: 2026-02-20
|
||||||
company: "Devoted Health"
|
|
||||||
deal_stage: active
|
|
||||||
source: "POP Act H.R.5433/S.2836 September 2025; Break Up Big Medicine Act Warren/Hawley February 2026; Frier Levitt POP Act analysis 2025; Sheppard Health Law analysis 2025; AJMC analysis February 2026; On Healthcare Tech impact analysis February 2026"
|
source: "POP Act H.R.5433/S.2836 September 2025; Break Up Big Medicine Act Warren/Hawley February 2026; Frier Levitt POP Act analysis 2025; Sheppard Health Law analysis 2025; AJMC analysis February 2026; On Healthcare Tech impact analysis February 2026"
|
||||||
confidence: proven
|
confidence: proven
|
||||||
---
|
---
|
||||||
|
|
|
||||||
|
|
@ -1,6 +1,6 @@
|
||||||
---
|
---
|
||||||
description: The three ancient enemies of humanity emerged from specific conditions of the agricultural revolution -- dense populations dependent on staple crops domestic animals and sedentary property -- and increasing specialization has ameliorated all three within the last century
|
description: The three ancient enemies of humanity emerged from specific conditions of the agricultural revolution -- dense populations dependent on staple crops domestic animals and sedentary property -- and increasing specialization has ameliorated all three within the last century
|
||||||
type: framework
|
type: claim
|
||||||
domain: health
|
domain: health
|
||||||
source: "Architectural Investing, Ch. Burden of Agriculture; Diamond (Guns Germs and Steel); Harari (Sapiens; Homo Deus)"
|
source: "Architectural Investing, Ch. Burden of Agriculture; Diamond (Guns Germs and Steel); Harari (Sapiens; Homo Deus)"
|
||||||
confidence: likely
|
confidence: likely
|
||||||
|
|
|
||||||
|
|
@ -1,6 +1,6 @@
|
||||||
---
|
---
|
||||||
description: Derived using the 8-component template -- three core interrelated layers (VBC payment alignment, AI-enabled proactive care, continuous biometric monitoring) plus contested dimensions around social determinants and administrative simplification, classified as a weak attractor with multiple locally stable configurations
|
description: Derived using the 8-component template -- three core interrelated layers (VBC payment alignment, AI-enabled proactive care, continuous biometric monitoring) plus contested dimensions around social determinants and administrative simplification, classified as a weak attractor with multiple locally stable configurations
|
||||||
type: framework
|
type: claim
|
||||||
domain: health
|
domain: health
|
||||||
created: 2026-03-01
|
created: 2026-03-01
|
||||||
source: "Healthcare attractor state derivation using vault knowledge + 2026 industry research; Rumelt Good Strategy Bad Strategy; Devoted Health analysis; CMS data; OECD comparisons; Singapore model"
|
source: "Healthcare attractor state derivation using vault knowledge + 2026 industry research; Rumelt Good Strategy Bad Strategy; Devoted Health analysis; CMS data; OECD comparisons; Singapore model"
|
||||||
|
|
|
||||||
Loading…
Reference in a new issue